-- To evaluate the concept of trust between patient and physician and the extent to which it factors into treatment decisions, compliance and intrinsic benefits such as physician job satisfaction
-- To quantify the degree to which, and in what situations physicians are apprehensive in communicating with patients with early breast cancer and how it affects physicians' views of their work
-- To measure patient and physician satisfaction with treatments and understand the role of the relationship between the patient and the physician in making treatment decisions
-- To understand the degree to which time limitations are present in patient consultations and how this affects the perceived quality of the visit
AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4 Good Index.
ARIMIDEX is a trademark, the property of the AstraZeneca group of companies.
Contact: Odette England, Global PR Manager, 'Arimidex', Mobile: +44(0)7894-584-245, Email: odette.england@astrazeneca.com; Mark Haydon, Account Director, ShireHealthPR, Mobile: +44-(0)-7968-139-370, Email: mark.haydon@shirehealthpr.com
